Rapamycin sensitive mTOR activation mediates nerve growth factor (NGF) induced cell migration and pro-survival effects against hydrogen peroxide in retinal pigment epithelial cells

被引:59
作者
Cao, Guo-Fan [1 ]
Liu, Yuan [1 ]
Yang, Wen [1 ]
Wan, Jerry [2 ]
Yao, Jin [1 ]
Wan, Yinsheng [2 ]
Jiang, Qin [1 ]
机构
[1] Nanjing Med Univ, Affiliated Eye Hosp, Nanjing 210029, Jiangsu, Peoples R China
[2] Providence Coll, Dept Biol, Providence, RI 02918 USA
基金
中国国家自然科学基金;
关键词
Nerve growth factor; Hydrogen peroxide; mTOR; Cell survival; Cell migration; Retinal pigment epithelial cells; MACULAR DEGENERATION; OXIDATIVE STRESS; PROTEIN-KINASE; (-)-EPIGALLOCATECHIN GALLATE; POLY(ADP-RIBOSE) POLYMERASE; DOWN-REGULATION; RPE; DEATH; APOPTOSIS; SYSTEM;
D O I
10.1016/j.bbrc.2011.09.094
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Patients with age related macular degeneration (AMD) have a loss of vision in the center of the visual field. Oxidative stress plays an important role in this progress. Nerve growth factor (NGF) is important for the survival and maintenance of sympathetic and sensory neurons and NGF eye drops improve visual acuity and electro-functional activity in patients with AMD. However, the molecular mechanisms and signaling events involved in this have not been fully investigated. Using cultured human retinal pigment epithelial (RPE) cells, we demonstrate here that NGF protects RPE cells against hydrogen peroxide (H(2)O(2))-induced cell apoptosis. NGF also induces RPE cell migration, the latter is important for retinal regeneration and the recovery from AMD. H(2)O(2) decreases S6 phosphorylation and cell viability, which is restored by NGF. Rapamycin, the pharmacologic inhibitor of mammalian target of rapamycin (mTOR), diminished NGF-induced S6 phosphorylation, cell migration and protective effects against oxidative stress. Collectively, we conclude that activation of rapamycin sensitive mTOR signaling mediates NGF induced cell migration and pro-survival effects in H(2)O(2) treated RPE cells. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:499 / 505
页数:7
相关论文
共 35 条
[21]
Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult [J].
Lambiase, A ;
Tirassa, P ;
Micera, A ;
Aloe, L ;
Bonini, S .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (10) :3800-3806
[22]
Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension [J].
Lambiase, A ;
Centofanti, M ;
Micera, A ;
Manni, GL ;
Mattei, E ;
DeGregorio, A ;
deFeo, G ;
Bucci, MG ;
Aloe, L .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1997, 235 (12) :780-785
[23]
Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: Biochemical and structural evidence [J].
Lambiase, Alessandro ;
Pagani, Lucia ;
Di Fausto, Veronica ;
Sposato, Valentina ;
Coassin, Marco ;
Bonini, Stefano ;
Aloe, Luigi .
BRAIN RESEARCH, 2007, 1127 (01) :45-51
[24]
The Expanding Universe of Neurotrophic Factors: Therapeutic Potential in Aging and Age-Associated Disorders [J].
Lanni, C. ;
Stanga, S. ;
Racchi, M. ;
Govoni, S. .
CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (06) :698-717
[25]
Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration [J].
Liang, FQ ;
Godley, BF .
EXPERIMENTAL EYE RESEARCH, 2003, 76 (04) :397-403
[26]
Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases [J].
Micera, A ;
Lambiase, A ;
Aloe, L ;
Bonini, S ;
Levi-Schaffer, F ;
Bonini, S .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (06) :411-417
[27]
Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B [J].
Mohan, R ;
Sivak, J ;
Ashton, P ;
Russo, LA ;
Pham, BQ ;
Kasahara, N ;
Raizman, MB ;
Fini, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :10405-10412
[28]
Nowak JZ, 2006, PHARMACOL REP, V58, P353
[29]
Nowak Michal, 2005, Klin Oczna, V107, P715
[30]
PACIFICI RE, 1991, GERONTOLOGY, V37, P166